Pulmonary surfactant phosphatidylcholines induce immunological adaptation of alveolar macrophages

• Published in: Molecular immunology 2020-06, Vol.122, p.163-172
• Main Authors: da Costa Loureiro, Luma, da Costa Loureiro, Luana, Gabriel-Junior, Edson Alves, Zambuzi, Fabiana Albani, Fontanari, Caroline, Sales-Campos, Helioswilton, Frantz, Fabiani Gai, Faccioli, Lúcia Helena, Sorgi, Carlos Arterio
• Format: Article
• Language: English
• Subjects: Alveolar macrophage; Epigenetics; Inflammation; Phosphatidylcholine; Pulmonary surfactant; Trained immunity
• ISSN: 0161-5890; 1872-9142
• DOI: 10.1016/j.molimm.2020.04.010

•POPC and PONPC enhanced macrophage inflammatory response to LPS.•POPC and PONPC modulated the expression of innate immunity receptors.•POPC and PONPC induced immunological adaptations by epigenetic modifications.•PONPC impaired the phagocytic activity of macrophage. Pulmonary surfactant plays an important role in lung surface tension, defense against invading pathogens, and immune response. Furthermore, alveolar macrophages (AM) that comprise the front line of immune defense against inhaled microorganisms are covered by a layer of pulmonary fluid. Phosphatidylcholines (PCs), including unsaturated lipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), are the most prevalent phospholipids in pulmonary surfactant. POPC reacts with ozone to produce 1-palmitoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phosphocholine (PONPC), a soluble mediator that initiates an inflammatory reaction in the lungs. However, the modulatory effects of POPC and PONPC on biology and activity of AM remain inconclusive. The exposure of AM (cell line AMJ2-C11) to POPC and PONPC was not directly related to the production of inflammatory mediators. However, AM, pre-incubated with POPC or PONPC, showed enhanced response after lipopolysaccharide (LPS) stimulation, and increased the production of nitric oxide and cytokines. This phenomenon was also observed for classical-polarized macrophages (M1). This increment on the production of inflammatory mediators was not associated with macrophage polarization, but with up-regulation of Tlr4 and Myd88 gene expression, which was in accordance with the adaptation of immune cells. This observation was confirmed by the histone acetylation epigenetic pathway. In contrast to the priming effect of POPC on AM activity, a harmful immune response, induced on incubation with PONPC, improved prostaglandin E2 (PGE2) formation, resulting in diminished bacterial phagocytosis. Additionally, PONPC induced production of CXCL1/KC, which potentially mediates neutrophil recruitment and enhances tissue inflammation. These results disclosed another dynamic mechanism by which pulmonary surfactant lipids (natural or oxidized) primed macrophage activity, thus affecting lung host defense.